Sorafenib Offers Survival Improvements in Ovarian Cancer

Sorafenib combined with topotecan and then continued as maintenance therapy offered a significant improvement in survival outcomes in women with platinum-resistant ovarian cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news